HALO Price Prediction Next Week
Analysis and Insights
News Sentiment and Analyst Ratings:
- Positive Analyst Sentiment: Analysts have maintained a bullish outlook on Halozyme (HALO), with Morgan Stanley setting a price target of $67.00 and an average consensus target of $66.11, indicating a 10.6% upside potential.
- Insider Activity: A director sold 1,795 shares, which could signal insider caution despite the positive analyst outlook.
- Patent Dispute: HALO is involved in a patent dispute with Merck over a cancer drug, which might impact its partnerships and revenue.
Technical Indicators:
- Current Price: $61.74 as of 2025-03-10.
- RSI (14): 70.87, indicating overbought conditions.
- MACD: Positive but weakening momentum.
- Fibonacci Levels: Resistance at $61.90 and $63.65; support at $59.06.
Price Prediction and Recommendation:
- Prediction: The stock may face resistance at $62.00 and could correct to $60.50 next week.
- Recommendation: Sell or hold, as the stock is near its 52-week high and shows signs of potential pullback.
HALO Similar Chart Price Prediction
The price of HALO is predicted to go up -12.27%, based on the high correlation periods with YELP. The similarity of these two price pattern on the periods is 96.06%.
HALO
YELP
Down: -12.27%Similarity: 96.06%
HALO Revenue Forecast
HALO EPS Forecast
HALO FAQs
What is HALO revenue forecast for next quarter？
What is HALO eps forecast for next quarter？
HALO Analyst's Forecast
Mohit Bansal
Wells Fargo
Hold
2025-01-13
Price Target
$62 → $57
Upside
+5.28%
Wells Fargo lowered the firm's price target on Halozyme to $57 from $62 and keeps an Equal Weight rating on the shares. The firm said on Friday that it is updating its model for new Halozyme guidance but continues to see terminal growth issues due to lack of new deals. Wells sees near-term upside, but royalty step down post ENHANZE patent expiry keeps it on the sidelines.
Joseph Catanzaro
Piper Sandler
Hold
2025-01-10
Price Target
$52 → $53
Upside
+0.38%
Joseph Catanzaro
Piper Sandler
Hold
2024-11-04
Price Target
$51 → $52
Downside
-11.44%
